NCT00833911View on ClinicalTrials.gov

An Open-Label Long-term Safety Study of Tramadol HCl OAD (Once A Day) 300 mg in the Treatment of Pain Due to Osteoarthritis of the Knee

PHASE3CompletedINTERVENTIONAL
Enrollment

392

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

July 31, 2004

Study Completion Date

July 31, 2004

Conditions
Osteoarthritis, Knee
Interventions
DRUG

Tramadol Once A Day

Sponsors

Lead Sponsor

Labopharm Inc.
All Listed Sponsors
lead

Labopharm Inc.

INDUSTRY

NCT00833911 - An Open-Label Long-term Safety Study of Tramadol HCl OAD (Once A Day) 300 mg in the Treatment of Pain Due to Osteoarthritis of the Knee | Biotech Hunter | Biotech Hunter